Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Comparison of two clinical scales for causality assessment in hepatotoxicity.

Lucena MI, Camargo R, Andrade RJ, Perez-Sanchez CJ, Sanchez De La Cuesta F.

Hepatology. 2001 Jan;33(1):123-30.

PMID:
11124828
2.

Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.

García-Cortés M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ; Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Geham)..

Aliment Pharmacol Ther. 2008 May;27(9):780-9. doi: 10.1111/j.1365-2036.2008.03655.x.

3.

Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity.

Miljkovic MM, Dobric S, Dragojevic-Simic V.

J Clin Pharm Ther. 2012 Apr;37(2):196-203. doi: 10.1111/j.1365-2710.2011.01282.x.

PMID:
21718339
4.

Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity.

Miljkovic MM, Dobric S, Dragojevic-Simic V.

Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):272-85. doi: 10.1002/pds.2081.

PMID:
21351309
5.

Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods.

Teschke R, Frenzel C, Schulze J, Eickhoff A.

World J Gastroenterol. 2013 May 21;19(19):2864-82. doi: 10.3748/wjg.v19.i19.2864. Review.

6.

Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment.

Teschke R, Fuchs J, Bahre R, Genthner A, Wolff A.

J Clin Pharm Ther. 2010 Oct;35(5):545-63. doi: 10.1111/j.1365-2710.2009.01131.x.

PMID:
20831679
7.

Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?

Teschke R, Schmidt-Taenzer W, Wolff A.

Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):567-82. doi: 10.1002/pds.2127.

PMID:
21702069
8.

Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports.

Teschke R, Glass X, Schulze J.

Regul Toxicol Pharmacol. 2011 Dec;61(3):282-91. doi: 10.1016/j.yrtph.2011.08.008.

PMID:
21893153
9.

 Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement.

Teschke R, Frenzel C, Wolff A, Herzog J, Glass X, Schulze J, Eickhoff A.

Ann Hepatol. 2012 Jul-Aug;11(4):500-12.

10.

Flutamide-induced hepatotoxicity: report of a case series.

García Cortés M, Andrade RJ, Lucena MI, Sánchez Martínez H, Fernández MC, Ferrer T, Martín-Vivaldi R, Peláez G, Suárez F, Romero-Gómez M, Montero JL, Fraga E, Camargo R, Alcántara R, Pizarro MA, García-Ruiz E, Rosemary-Gómez M.

Rev Esp Enferm Dig. 2001 Jul;93(7):423-32. English, Spanish. Erratum in: Rev Esp Enferm Dig 2001 Oct;93(10):634.

PMID:
11685939
11.

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.

Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K, García-Cortés M, Fernández MC, Pelaez G, Rodrigo L, Durán JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Muņoz-Yagüe T, Salmerón J, Hidalgo R.

Hepatology. 2006 Dec;44(6):1581-8.

PMID:
17133470
12.

Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests.

Teschke R, Frenzel C, Schulze J, Schwarzenboeck A, Eickhoff A.

World J Hepatol. 2013 Jul 27;5(7):353-63. doi: 10.4254/wjh.v5.i7.353.

13.
14.

Suspected Greater Celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe.

Teschke R, Glass X, Schulze J, Eickhoff A.

Eur J Gastroenterol Hepatol. 2012 Mar;24(3):270-80. doi: 10.1097/MEG.0b013e32834f993f. Review.

PMID:
22189691
15.

Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?

Teschke R, Eickhoff A, Schulze J.

J Clin Transl Hepatol. 2013 Sep;1(1):59-74. doi: 10.14218/JCTH.2013.D002X. Review.

16.

Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?

Teschke R, Wolff A.

Regul Toxicol Pharmacol. 2011 Feb;59(1):1-7. doi: 10.1016/j.yrtph.2010.09.006. Review.

PMID:
20854865
17.

Herbal hepatotoxicity and WHO global introspection method.

Teschke R, Eickhoff A, Wolff A, Frenzel C, Schulze J.

Ann Hepatol. 2013 Jan-Feb;12(1):11-21. Review.

18.

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, González-Grande R, Pizarro A, Durán JA, Jiménez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmerón J, Martin-Vivaldi R; Spanish Group for the Study of Drug-Induced Liver Disease..

Gastroenterology. 2005 Aug;129(2):512-21. Erratum in: Gastroenterology. 2005 Nov;129(5):1808.

PMID:
16083708
19.

[Tetrabamate-induced hepatotoxicity. Report of seven cases and literature review].

López-Torres E, Lucena MI, Andrade RJ, García Ruiz E, Fernández MC, Peláez G, Soria de la Cruz MJ, Pizarro A.

Gastroenterol Hepatol. 2002 Dec;25(10):589-93. Review. Spanish.

PMID:
12459120
20.

Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.

Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A.

World J Hepatol. 2014 Jan 27;6(1):17-32. doi: 10.4254/wjh.v6.i1.17. Review.

Items per page

Supplemental Content

Support Center